Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

US FDA Needs ‘More Clout’ To Get Supply Chain Information, Califf Says

Oct 31 2022

• By Brenda Sandburg

Supply chain — FDA wants information about company supply chains • Source: Shutterstock

Related Content

US FDA Supply Chain Guidance Includes More Stakeholders, More Risks Than CARES Act

May 23 2022

After ‘Clean’ User Fee Renewal, Will Programs Held Hostage Be Enough To Drive A Broader Reform Bill?

Sep 28 2022

Greater US FDA And Manufacturer Transparency Recommended As Key to Supply Chain Resilience

Mar 09 2022

‘Industry Failing On Evidence Generation,’ US FDA’s Califf Says Of Accelerated Approvals

Oct 18 2022

US FDA Panel Says Covis’ Makena Should Be Withdrawn – And This Time It Wasn’t Close

Oct 19 2022

Accelerated Approval: US FDA Review Of Expedited Program Could Bring More Withdrawals

Feb 24 2021

Democrats, Republicans Agree US FDA’s Food Safety Programs Need Help, Disagree On How

May 26 2022

Pink Sheet Podcast Special: Assessing US FDA Commissioner Robert Califf’s First 100 Days

May 31 2022

Related Companies

Biogen, Inc.

Additional Topics

United States International Supply Chain Manufacturing FDA Review Pathway Coronavirus COVID-19 Regulation Consumer Compliance Commercial Distribution Enforcement Policy Politics Retail Safety OTC Drugs Dietary Supplements BioPharmaceutical

More from Supply Chain

More from HBW Insight

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window